In breaking news CNBC’s Bob Pisani says Citigroup will be pricing its preferred offering, $25 par, at a yield of 8.875 percent.

We know you want trading ideas. And the Fast Money desk has plenty of them!

The Fast Money traders often say 'buy' when the news seems the very worst. But is Toyota the exception to this rule?

We've been talking a lot lately about the decline in the Vix. Is this a good time to buy some protection?

On the eve of the 1st year anniversary of the March 2009 lows, we can’t help but wonder could the blossoming debt derail this bull?

A handful of biopharma stocks could be pretty volatile this week and we're talking right up until Friday.

With Arch Coal, Massey and Peabody all up by double digits over the past month, what’s next for coal? Find out from an insider!

Considering the S&P 500 is up about 70% from its 12 year closing low on March 9th how can you protect and profit? Mike Khouw suggests using options!

Look out below. Widely followed strategist Doug Kass thinks 5 stocks are about to sink.

The first Imax 3D epic since Avatar hit theaters on Friday. But before you place your bets there's something you should know!

Sure the market shrugged off Greece for the most part, but are more serious financial woes in Europe about to surface?

Does the recent flurry of M&A signal a top or the beginning of the next leg higher?

Every eight seconds a baby boomer turns 50 and though it’s often the best time of life, the 50's can also be the beginning of something else entirely.

On March 9th it will be one year since those much talked about 2009 lows. But don’t be fooled. That day is just as relevant this year as it was last.

If you can't beat 'em, buy 'em. With stocks relatively cheap, many companies are looking to acquisitions to jazz their stock price. Also Options Action w/ Mike Khouw

Evidently Christmas came very, very early for retailers this year – in February!

Following you'll find several catalysts that could move the market - or sectors of the market - on Thursday March 4th. How should you trade it?

We talk about it a lot on the Fast Money desk, the massive growth of ETFs. But check this out.

If you’ve been playing health care on hopes of gridlock in Congress, you should read this.

A flurry of M&A has turned the spotlight on Pharma and more. What names should be on your radar?